Back to Companies
LIGAND PHARMACEUTICALS INC
LGNDOTCCIK: 0000886163
LIGAND PHARMACEUTICALS INC (LGND) shows 50 recent insider filings from 10 insiders, with all of them on the sell side. With $0 in purchases and $33.4M in sales, the recent tape is heavily weighted toward selling (net sales of $33.4M). Espinoza Octavio (Chief Financial Officer) is the most active by dollar volume, and the single largest transaction was $12.8M by Espinoza Octavio. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$64.0M
Purchases
$0
Sales
$33.4M
Unique Insiders
10
Recent Insider Trades
50 loaded
| Aug 14 | LGND LIGAND PHARMACEUTICALS INC | Haas Jason | Director | Sell | $2.1M |
| Aug 14 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Sell | $9.2M |
| Aug 4 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | Sell | $1.4M |
| Jul 6 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Other | $2.7K |
| Jul 6 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | Sell | $1.6M |
| Jul 6 | LGND LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer, Director | Other | $21.2K |
| Jun 18 | LGND LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Director | Sell | $544.8K |
| Jun 15 | LGND LIGAND PHARMACEUTICALS INC | Haas Jason | Director | Sell | $1.7M |
| Jun 12 | LGND LIGAND PHARMACEUTICALS INC | LAMATTINA JOHN L | Director | Sell | $1.2M |
| Jun 12 | LGND LIGAND PHARMACEUTICALS INC | Aryeh Jason | Director | Sell | $1.3M |
| Jun 9 | LGND LIGAND PHARMACEUTICALS INC | Haas Jason | Director | Grant | $696.3K |
| Jun 9 | LGND LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | Grant | $696.3K |
| Jun 9 | LGND LIGAND PHARMACEUTICALS INC | LAMATTINA JOHN L | Director | Grant | $696.3K |
| Jun 9 | LGND LIGAND PHARMACEUTICALS INC | Zimmermann Martine | Director | Grant | $739.4K |
| Jun 9 | LGND LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Director | Grant | $696.3K |
| Jun 9 | LGND LIGAND PHARMACEUTICALS INC | Gray Nancy Ryan | Director | Grant | $696.3K |
| Jun 2 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | Sell | $1.1M |
| May 28 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Exercise | $199.9K |
| May 4 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | Sell | $1.2M |
| May 14 | LGND LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | Sell | $563.1K |
| Apr 2 | LGND LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | Sell | $94.4K |
| Apr 2 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | Sell | $1.0M |
| Mar 25 | LGND LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Director | Sell | $207.9K |
| Mar 13 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Sell | $687.8K |
| Mar 31 | LGND LIGAND PHARMACEUTICALS INC | LAMATTINA JOHN L | Director | Sell | $433.8K |
| Mar 6 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | Sell | $1.0M |
| Mar 6 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Sell | $2.8M |
| Mar 5 | LGND LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Director | Sell | $409.9K |
| Mar 27 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Grant | $4.8M |
| Mar 4 | LGND LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | Sell | $93.6K |
| Feb 18 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Grant | $2.2M |
| Feb 18 | LGND LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer, Director | Grant | $6.0M |
| Feb 4 | LGND LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | Sell | $91.5K |
| Jan 6 | LGND LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | Sell | $88.5K |
| Jan 6 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Other | $765 |
| Dec 18 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Exercise | $328.6K |
| Dec 16 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Sell | $339.7K |
| Dec 8 | LGND LIGAND PHARMACEUTICALS INC | Aryeh Jason | Director | Exercise | $282.8K |
| Dec 9 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Tax withheld | $344.2K |
| Dec 8 | LGND LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer, Director | Gift | $0 |
| Dec 3 | LGND LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | Sell | $91.5K |
| Nov 12 | LGND LIGAND PHARMACEUTICALS INC | Gray Nancy Ryan | Director | Sell | $1.4M |
| Nov 12 | LGND LIGAND PHARMACEUTICALS INC | LAMATTINA JOHN L | Director | Sell | $858.6K |
| Nov 5 | LGND LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | Sell | $89.2K |
| Oct 3 | LGND LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | Sell | $83.8K |
| Sep 24 | LGND LIGAND PHARMACEUTICALS INC | Aryeh Jason | Director | Sell | $1.7M |
| Sep 24 | LGND LIGAND PHARMACEUTICALS INC | Zimmermann Martine | Director | Tax withheld | $19.6K |
| Sep 4 | LGND LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | Sell | $75.8K |
| Aug 12 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | Tax withheld | $198.8K |
| Aug 5 | LGND LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | Sell | $61.6K |
50 filings+